<DOC>
	<DOCNO>NCT00982293</DOCNO>
	<brief_summary>The purpose study see use device call Resonator , put low level electromagnetic field , effect blood glucose A1c level people Type 2 Diabetes .</brief_summary>
	<brief_title>The Application Extremely Low Level Magnetic Fields Adjunctive Treatment Type II Diabetes</brief_title>
	<detailed_description>The purpose pilot study determine whether application magnetic field generate Resonator TM , adjunctive therapy oral medication result statistically significant reduction fast blood glucose level , post prandial glucose level hemoglobin A1c level . The study also investigate induced change serum lipid .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Current diagnosis Type 2 Diabetes Mellitus hemoglobin A1c level 7.5 % , despite management diabetes diet and/or medication . Subject currently perform routine finger stick blood sugar test part current diabetes disease management regimen . Subject ambulatory Subject stable oral medication regimen without significant side effect least three ( 3 ) month ( stable insulin regimen NOT permissible ) ; willingness ability maintain stable oral medication regimen throughout course study . If agent suspect contribute hyperglycemia ( see list ) , subject must stable dose ( ) agent ( ) 6 month prior study initiation . Hemoglobin A1c level within 0.8 % range patient mean A1c level last two document determination , must within 2 year baseline test date . Willingness test finger stick blood sugar accord prescribe protocol . Willingness lab test blood draw perform accord prescribe protocol Willingness maintain stable diet activity regimen duration study . Willing able abstain partake nonessential ( physician order ) exist new treatment improve serum blood sugar level Willing able abstain medication could affect diabetes mellitus and/or associate symptom duration study Adequate contraceptive measure females subject Any ethnic background Change medical regimen within 3 month prior initiation study . Any sign type 1 diabetes mellitus ( include history ketoacidosis new requirement insulin therapy within 6 month period prior study initiation ) . Active significant infectious process within 3 week study initiation cause wide fluctuation finger stick blood sugar level Change BMI great 6 % within 3 month period prior study initiation Any plan revascularization procedure . Symptomatic congestive heart failure . Leg foot ulceration open wound Gangrene . History intermittent claudication Hemodialysis Currently treat malignancy Currently treat oral intravenous catabolic steroid Reported consumption 14 alcoholic drink per week . Pregnant , breast feeding , plan pregnancy prior end participation Developmental disability cognitive impairment would make difficult subject partake clinical study , include adequate comprehension inform consent form ability record necessary measurement Uncontrolled hypertension Uncontrolled atrial fibrillation uncontrolled arrythmias , e.g . tachycardia , bradycardia Uncontrolled seizure disorder Uncontrolled , unstable , untreated medical condition may significantly impact subject 's health ability complete entire study , opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>